Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tocilizumab Monotherapy”

31 trials

Showing 20 of 31 results

Large-scale testing (Phase 3)Study completedNCT01063062
What this trial is testing

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Post-approval studies (Phase 4)Study completedNCT01010503
What this trial is testing

Tocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 32
Not applicableStudy completedNCT01669902
What this trial is testing

An Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Post-approval studies (Phase 4)UnknownNCT02087696
What this trial is testing

Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Spanish Foundation of Rheumatology 122
Large-scale testing (Phase 3)Study completedNCT01941095
What this trial is testing

Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 100
Post-approval studies (Phase 4)Study completedNCT04157010
What this trial is testing

Tocilizumab REMission in Early RA

Who this might be right for
Rheumatoid Arthritis
University of Leeds 20
Large-scale testing (Phase 3)Study completedNCT00891020
What this trial is testing

Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 886
Large-scale testing (Phase 3)Study completedNCT02046603
What this trial is testing

Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 162
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Not applicableStudy completedNCT02648035
What this trial is testing

EMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 200
Not applicableStudy completedNCT02402686
What this trial is testing

Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 353
Large-scale testing (Phase 3)Study completedNCT00109408
What this trial is testing

Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 673
Large-scale testing (Phase 3)Study completedNCT01941940
What this trial is testing

Evaluate Efficacy of Tocilizumab Administered as Monotherapy or in Combination With Methotrexate and/or Other Disease Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (RA) Participants

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 227
Large-scale testing (Phase 3)Study completedNCT01034137
What this trial is testing

Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 317
Post-approval studies (Phase 4)Study completedNCT01119859
What this trial is testing

Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 326
Not applicableStudy completedNCT01705730
What this trial is testing

A Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in Monotherapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 71
Not applicableStudy completedNCT02608112
What this trial is testing

Study to Describe Real World Drug Retention Rate of the Tocilizumab at One Year

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 291
Testing effectiveness (Phase 2)Study completedNCT03062579
What this trial is testing

A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum DisordersNeuromyelitis OpticaDevic's Disease
Fu-Dong Shi 10
Not applicableStudy completedNCT01791205
What this trial is testing

ARMONIA: An Observational Study of Biologic Drugs in Monotherapy or Combination With DMARDs in Italian Clinical Practice and the Efficacy and Safety of RoActemra/Actemra (Tocilizumab) Monotherapy in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 304
Early research (Phase 1)Study completedNCT02404558
What this trial is testing

Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sanofi 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation